{"name":"InnoPharmax Inc.","slug":"innopharmax-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Neuroscience","slug":"neuroscience","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"D07001-Softgel Capsules","genericName":"D07001-Softgel Capsules","slug":"d07001-softgel-capsules","indication":"Major depressive disorder","status":"phase_3"}]}],"pipeline":[{"name":"D07001-Softgel Capsules","genericName":"D07001-Softgel Capsules","slug":"d07001-softgel-capsules","phase":"phase_3","mechanism":"D07001-Softgel Capsules is a medication that works by inhibiting the reuptake of a specific neurotransmitter.","indications":["Major depressive disorder","Generalized anxiety disorder"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMioAJBVV95cUxNeUZsTVVMVzZ5TWlULVEzTW1PejNkODhMd3RQdFRRNDlLd214UE84ZERwbEprWl9WQWtHQzJhR18xdUYwQndtU3RqRExVUTV3UGpsOGVaR3JDbFl6OF9MNkJnc0Y1SmFJVTBjT1pobkpYVk9zdXZ0VVBScUIzdlFuZ2dXcHlIS2hRWmVFZDlWalEwcG81LTB2anpuVnQ3LVFvNmgzaGU2dklGYVRxOHViQXVoUE1wdHU5VTNyUXhIdUl2c2lxLTJKYnU3eTRYX1dZeE5Ua01RNVllMlptcEpTUVB6cFlKWEtTU1hNX2QxZVMyVTZTVVB4Tm0wOXZ6Z1BoYmhLZlpELUNIV1RNSFl4UVNyeEJmSWREUFlkRElGVUc?oc=5","date":"2026-03-02","type":"regulatory","source":"PR Newswire UK","summary":"Biliary Tract Cancer Market is Predicted to Exhibit Remarkable Growth at a CAGR of 10.1% During the Forecast Period (2025-2034) | DelveInsight - PR Newswire UK","headline":"Biliary Tract Cancer Market is Predicted to Exhibit Remarkable Growth at a CAGR of 10.1% During the Forecast Period (202","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_3":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}